Table 2.
The results of CAG in the study patients
| MS (MVR) (n=72) | MR (MVR) (n=93) | AS (AVR) (n=40) | AR (AVR) (n=36) | P value | |
|---|---|---|---|---|---|
| Presence of CAD* | 19 (26.4%) | 39 (42%) | 23 (57.5%) | 16 (44.4%) | 0.01 |
| Gensini score** | 2.97±8.75 | 11.02±25.26 | 11.20±28.26 | 7.55±16.98 | 0.077 |
| CABG (%) | 6 (8.3%) | 12 (12.9%) | 10 (25%) | 6 (16.7%) | 0.102 |
| LVEF (%) | 54.93±7.45 | 50.29±12.05 | 53.12±10.30 | 50.25±13.07 | 0.03 |
CAG, Coronary artery angiography; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement. CAD, Coronary artery disease; CABG, Coronary artery bypass graft; LVEF, Left ventricular ejection fraction.
*The prevalence of CAD was significantly higher in AS group compared to MS group (p=0.002). The prevalence of CAD was significantly higher in MR group compared to MS group (p=0.02).
**The Gensini score was significantly higher in MR group compared to MS group (p=0.005).